Omada Health (Nasdaq: OMDA), the virtual between-visit healthcare provider, today announced that members of senior management will participate in the Goldman Sachs 47th Annual Global Healthcare ...

Hinge Health (NYSE:HNGE) released a five year claims analysis on its digital musculoskeletal program, reporting sustained reductions in surgeries and healthcare spending for employers and health plans ...

I initiate coverage on Omada Health with a Hold rating. The current price of ~$16 offers a not attractive enough risk-reward despite the underlying business quality. Omada is a fundamentally good ...

Detailed price information for Omada Health Inc (OMDA-Q) from The Globe and Mail including charting and trades.

Detailed price information for Omada Health Inc (OMDA-Q) from The Globe and Mail including charting and trades.

Omada Health (OMDA) is scheduled to report Q1 earnings on May 7, 2026. Analysts estimate EPS of $-0.06 and quarterly revenue of $74.37M. In the most recent quarter (Q4), Omada Health reported EPS of ...

GLP-1 consumer apps can help patients stay on track but have no evidence base; clinical-grade apps can do more but are not ...

Healthcare startup exits are improving but remain highly selective. Jack Euston, general partner Fountain Health Partners, expects the next exit cycle to reward AI-enabled, workflow-embedded companies ...

There are no SEC filings that match your filter(s), please update your selections to return more records. Nasdaq provides company’s SEC filings, which are financial statements and reports filed ...

A growing wave of clinical trials is testing whether principles from behavioral economics can improve adherence to weight management strategies, one of the most persistent challenges in obesity care.

The obesity-drug race is becoming less about losing weight and more about keeping it off. Why it matters: As more GLP-1 drugs ...